These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10067132)

  • 21. Combination therapy as first-line treatment of arterial hypertension.
    Ruzicka M; Leenen FH
    Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multifactorial nature of hypertension: the greatest challenge for its treatment?
    Waeber B; Brunner HR; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
    Messerli FH; Michalewicz L
    J Hypertens Suppl; 1998 Jan; 16(1):S81-4. PubMed ID: 9534103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension - dosing recommendations at beginning and end of treatment].
    Middeke M
    Ther Umsch; 2008 Oct; 65(10):577-84. PubMed ID: 18821516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension management: rationale for triple therapy based on mechanisms of action.
    Neutel JM; Smith DH
    Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The strategy, tactical approaches and choice of combination therapy in the treatment of patients with arterial hypertension].
    Koziolova NA; Shatunova IM
    Kardiologiia; 2013; 53(10):71-81. PubMed ID: 24645557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fixed-drug combinations for hypertension].
    Sato N; Hasebe N
    Nihon Rinsho; 2014 Aug; 72(8):1477-84. PubMed ID: 25167756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.